Year archive

Clover Biopharmaceuticals, Ltd. — 2022 filings

All 65 regulatory filings released by Clover Biopharmaceuticals, Ltd. (2197) in 2022, sourced directly from the official regulator.

65 Filings

2022 Period

2022 filings (65)

Filing	Released	Lang
Remuneration Committee - Terms of Reference Remuneration Information	2022-12-30	English
(1) GRANT OF OPTIONS AND RSUS (2) AMENDMENT TO VESTING SCHEDULE OF PREVIOUSLY GRANTED RSUS AND (3) AMENDMENT TO THE TRUST DEED Regulatory Filings	2022-12-15	English
Next Day Disclosure Returns Share Issue/Capital Change	2022-12-13	English
COMPLETION OF PLACING OF NEW SHARES UNDER GENERAL MANDATE Capital/Financing Update	2022-12-13	English
PLACING OF NEW SHARES UNDER GENERAL MANDATE Capital/Financing Update	2022-12-06	English
VOLUNTARY ANNOUNCEMENT - COVID-19 VACCINE (SCB-2019 (CPG 1018/ALUM)) INCLUDED FOR EMERGENCY USE IN THE PRC Regulatory Filings	2022-12-04	English
Monthly Return of Equity Issuer on Movements in Securities for the Month ended November 30, 2022 Regulatory Filings	2022-12-02	English
VOLUNTARY ANNOUNCEMENT - CLOVER'S VACCINE CANDIDATE REDUCED HOUSEHOLD TRANSMISSION OF SARS-COV-2 BY 84% IN STUDY PUBLISHED IN CLINICAL INFECTIOUS DISEASES Regulatory Filings	2022-11-30	English
Monthly Return of Equity Issuer on Movements in Securities for the Month ended October 31, 2022 Regulatory Filings	2022-11-03	English
LIST OF DIRECTORS AND THEIR ROLES AND FUNCTIONS Board/Management Information	2022-10-28	English
RESIGNATION OF A NON-EXECUTIVE DIRECTOR AND CHANGE IN COMPOSITION OF THE AUDIT COMMITTEE Board/Management Information	2022-10-28	English
TERMINATION OF DISCLOSABLE TRANSACTION IN RELATION TO THE LEASE AGREEMENT Regulatory Filings	2022-10-14	English
INSIDE INFORMATION - CLOVER PROVIDES UPDATE ON 2022 CORPORATE MILESTONES Regulatory Filings	2022-10-09	English
Monthly Return of Equity Issuer on Movements in Securities for the Month ended September 30, 2022 Share Issue/Capital Change	2022-10-05	English
VOLUNTARY ANNOUNCEMENT - CLOVER'S COVID-19 VACCINE CANDIDATE RECEIVES EU GMP CERTIFICATE Regulatory Filings	2022-09-20	English
VOLUNTARY ANNOUNCEMENT - CLOVER'S UNIVERSAL COVID-19 BOOSTER VACCINE CANDIDATE DEMONSTRATES SUPERIOR NEUTRALIZATION OF OMICORN BA.5 COMPARED TO INACTIVATED VACCINE Regulatory Filings	2022-09-20	English
Notification Letter and Request Form for Non-Registered Shareholders Report Publication Announcement	2022-09-16	English
2022 Interim Report Interim / Quarterly Report	2022-09-16	English
VOLUNTARY ANNOUNCEMENT - AMENDMENT TO THE ADVANCE PURCHASE AGREEMENT Capital/Financing Update	2022-09-15	English
VOLUNTARY ANNOUNCEMENT - CLOVER'S COVID-19 VACCINE CANDIDATE DEMONSTRATES SUPERIOR BOOSTER RESPONSES COMPARED TO INACTIVATED VACCINE Regulatory Filings	2022-09-06	English
Monthly Return of Equity Issuer on Movements in Securities for the Month ended August 31, 2022 Share Issue/Capital Change	2022-09-02	English
VOLUNTARY ANNOUNCEMENT - CLOVER'S COVID-19 BOOSTER VACCINE CANDIDATE DEMONSTRATES ROBUST NEUTRALIZATION OF DOMINANT OMICRON BA.5 SUBVARIANT Regulatory Filings	2022-08-30	English
VOLUNTARY ANNOUNCEMENT - POSITIVE PHASE 2/3 RESULTS IN ADOLESCENTS FOR CLOVER'S COVID-19 VACCINE Regulatory Filings	2022-08-25	English
INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHS ENDED JUNE 30, 2022 Interim / Quarterly Report	2022-08-24	English
DATE OF BOARD MEETING Report Publication Announcement	2022-08-11	English
Monthly Return of Equity Issuer on Movements in Securities for the Month ended July 31, 2022 Regulatory Filings	2022-08-04	English
GRANT OF OPTIONS PURSUANT TO THE POST-IPO SHARE OPTION PLAN AND GRANT OF RSUS PURSUANT TO THE RSU SCHEME Director's Dealing	2022-07-19	English
Monthly Return of Equity Issuer on Movements in Securities for the Month ended June 30, 2022 Regulatory Filings	2022-07-04	English
VOLUNTARY ANNOUNCEMENT - CLOVER'S COVID-19 VACCINE CANDIDATE DEMONSTRATES STRONG CROSS-NEUTRALIZATION AGAINST OMICRON AS A HOMOLOGOUS BOOSTER Regulatory Filings	2022-06-27	English
LIST OF DIRECTORS AND THEIR ROLES AND FUNCTIONS Board/Management Information	2022-06-20	English
APPOINTMENT OF NON-EXECUTIVE DIRECTORS Board/Management Information	2022-06-20	English
VOLUNTARY ANNOUNCEMENT - CLOVER DOSES FIRST PATIENT WITH SCB-219M IN PHASE 1 TRIAL FOR CHEMOTHERAPY-INDUCED THROMBOCYTOPENIA Regulatory Filings	2022-06-14	English
VOLUNTARY ANNOUNCEMENT - CLOVER DOSES FIRST PARTICIPANTS IN PHASE 3 TRIAL EVALUATING SCB-2019 AS A HETEROLOGOUS COVID-19 BOOSTER FOLLOWING PRIOR VACCINATION WITH INACTIVATED, MRNA OR VIRAL VECTOR VACC Regulatory Filings	2022-06-14	English
Monthly Return of Equity Issuer on Movements in Securities for the Month ended May 31, 2022 Share Issue/Capital Change	2022-06-07	English
INSIDE INFORMATION - BUSINESS UPDATE Regulatory Filings	2022-06-05	English
VOLUNTARY ANNOUNCEMENT - CLOVER DOSES FIRST PARTICIPANTS IN PHASE I TRIAL WITH SCB-2020S, A POTENTIALLY BROADLY PROTECTIVE CHIMERIC COVID-19 VACCINE CANDIDATE Regulatory Filings	2022-05-31	English
Fourth Amended and Restated Memorandum and Articles of Association Governance Information	2022-05-27	English
POLL RESULTS OF THE ANNUAL GENERAL MEETING HELD ON MAY 27, 2022 Declaration of Voting Results & Voting Rights Announcements	2022-05-27	English
GRANT OF OPTIONS PURSUANT TO THE POST-IPO SHARE OPTION PLAN AND GRANT OF RSUS PURSUANT TO THE RSU SCHEME Capital/Financing Update	2022-05-12	English
VOLUNTARY ANNOUNCEMENT - CLOVER'S BIVALENT COVID-19 VACCINE CANDIDATE DEMONSTRATES BROAD NEUTRALIZATION AGAINST OMICRON AND OTHER VARIANTS OF CONCERN Regulatory Filings	2022-05-05	English
Monthly Return of Equity Issuer on Movements in Securities for the Month ended April 30, 2022 Regulatory Filings	2022-05-05	English
LIST OF DIRECTORS AND THEIR ROLES AND FUNCTIONS Board/Management Information	2022-04-22	English
RESIGNATION OF A NON-EXECUTIVE DIRECTOR AND CHANGE IN COMPOSITION OF THE AUDIT COMMITTEE Board/Management Information	2022-04-22	English
FORM OF PROXY FOR USE AT ANNUAL GENERAL MEETING AGM Information	2022-04-21	English
NOTICE OF ANNUAL GENERAL MEETING AGM Information	2022-04-21	English
(1) PROPOSED GRANTING OF GENERAL MANDATES TO REPURCHASE SHARES AND TO ISSUE NEW SHARES; (2) PROPOSED GRANTING OF OPTIONS; (3) PROPOSED RE-ELECTION OF THE RETIRING DIRECTORS; (4) PROPOSE AGM Information	2022-04-21	English
VOLUNTARY ANNOUNCEMENT - CLOVER'S EFFICACY DATA IN PREVIOUSLY-INFECTED INDIVIDUALS IS PUBLISHED IN LANCET INFECTIOUS DISEASE Regulatory Filings	2022-04-20	English
VOLUNTARY ANNOUNCEMENT - CLOVER PRESENTS UPDATED DURABILITY AND BOOSTER DATA FOR COVID-19 VACCINE CANDIDATE AT WORLD VACCINE CONGRESS WASHINGTON 2022 Regulatory Filings	2022-04-19	English
2021 Annual Report Regulatory Filings	2022-04-19	English
Monthly Return of Equity Issuer on Movements in Securities for the Month ended March 31, 2022 Regulatory Filings	2022-04-06	English
GRANT OF OPTIONS PURSUANT TO THE POST-IPO SHARE OPTION PLAN AND GRANT OF RSUS PURSUANT TO THE RSU SCHEME Remuneration Information	2022-03-31	English
PROPOSED ADOPTION OF THE AMENDED AND RESTATED MEMORANDUM AND ARTICLES OF ASSOCIATION Regulatory Filings	2022-03-29	English
ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED DECEMBER 31, 2021 Annual Report	2022-03-29	English
CLARIFICATION ANNOUNCEMENT Regulatory Filings	2022-03-18	English
VOLUNTARY ANNOUNCEMENT - CLOVER'S COVID-19 VACCINE CANDIDATE DEMONSTRATED DURABLE HIGH PROTECTION AND STRONG IMMUNE RESPONSE AGAINST OMICRON AS A BOOSTER Regulatory Filings	2022-03-17	English
DATE OF BOARD MEETING Report Publication Announcement	2022-03-17	English
CHANGE OF ADDRESS OF HEADQUARTERS IN THE PRC Regulatory Filings	2022-03-11	English
Monthly Return of Equity Issuer on Movements in Securities for the Month ended February 28, 2022 Regulatory Filings	2022-03-04	English
VOLUNTARY ANNOUNCEMENT - INCLUSION ON THE HANG SENG COMPOSITE INDEX Regulatory Filings	2022-02-24	English
VOLUNTARY ANNOUNCEMENT - BUSINESS UPDATE Capital/Financing Update	2022-02-14	English
Monthly Return of Equity Issuer on Movements in Securities for the Month ended January 31, 2022 Regulatory Filings	2022-02-07	English
WAIVER FROM STRICT COMPLIANCE WITH RULE 10.07(1)(B) OF THE LISTING RULES Regulatory Filings	2022-01-28	English
VOLUNTARY ANNOUNCEMENT - PUBLICATION IN THE LANCET SHOWING THAT SCB-2019 (CPG 1018/ALUM) IN A PHASE 2/3 CLINICAL TRIAL DEMONSTRATES EFFICACY AGAINST ENTIRE SEVERITY SPECTRUM OF COVID-19 Regulatory Filings	2022-01-21	English
Monthly Return of Equity Issuer on Movements in Securities for the Month ended December 31, 2021 Regulatory Filings	2022-01-06	English
VOLUNTARY ANNOUNCEMENT - DOSING OF FIRST PARTICIPANTS WITH HOMOLOGOUS BOOSTER DOSE OF COVID-19 VACCINE CANDIDATE IN SPECTRA Regulatory Filings	2022-01-05	English